1-[(3,4-dimethylphenyl)sulfonyl]piperidine-4-carboxylic acid | | sc-338830 sc-338830A
| 1 g 5 g
| ¥3012.00 ¥10944.00
| | |
|
3-methyl-2-(piperidin-1-yl)butanoic acid hydrochloride | | sc-347106 sc-347106A
| 250 mg 1 g
| ¥2223.00 ¥4502.00
| | |
|
1-{4-[(2-methylpiperidin-1-yl)methyl]phenyl}methanamine | | sc-333687 sc-333687A
| 250 mg 1 g
| ¥2223.00 ¥4502.00
| | |
|
2-(((9H-Fluoren-9-yl)methoxy)carbonylamino)-2-(1-(7-tert-butoxy-7-oxoheptanoyl)piperidin-4-yl)acetic acid | 864685-37-0 | sc-357490 sc-357490A
| 250 mg 1 g
| ¥2144.00 ¥4400.00
| | |
|
(R)-(2,3-Dimethoxyphenyl)-4-piperidinemethanol | 243640-19-9 | sc-212663
| 2.5 mg
| ¥4287.00
| | |
(R)-(2,3-Dimethoxyphenyl)-4-piperidinemethanol is an intermediate used in the preparation of serotonin 5-HT2a receptor antagonists |
2-methyl-N-(piperidin-4-yl)propanamide hydrochloride | | sc-343064 sc-343064A
| 250 mg 1 g
| ¥2798.00 ¥5754.00
| | |
|
N-Didesmethyl Loperamide | 66164-06-5 | sc-212203 sc-212203A sc-212203B sc-212203C
| 1 mg 5 mg 10 mg 50 mg
| ¥2933.00 ¥3836.00 ¥6938.00 ¥27077.00
| | |
N-Didesmethyl Loperamide is a metabolite of Loperamide |
R-(-)-Flecainide | 99495-90-6 | sc-212623
| 1 mg
| ¥3836.00
| 2 | |
R-(−)-Flecainide is the R-Enantiomer of Flecainide |
(-)-trans-4-[4-(4′-Fluorophenyl)-3-piperidinylmethoxy]-2-methoxyphenol(Paroxetine metabolite) | 112058-90-9 | sc-213088
| 5 mg
| ¥4287.00
| | |
(-)-trans-4-[4-(4'-Fluorophenyl)-3-piperidinylmethoxy]-2-methoxyphenol(Paroxetine metabolite) 是一种帕罗西汀代谢物 |
S-(+)-Flecainide | 99495-92-8 | sc-212800
| 1 mg
| ¥3836.00
| 2 | |
S-(+)-Flecainide is an S-Enantiomer of Flecainide |